Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001021408-03-006292
Filing Date
2003-04-18
Accepted
2003-04-17 19:47:38
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR UNIGENE LABORATORIES, INC. d10k.txt 10-K 266196
3 DIRECTOR STOCK OPTION AGREEMENT dex1045.txt EX-10.45 19342
4 DIRECTOR STOCK OPTION AGREEMENT dex1046.txt EX-10.46 19357
5 DIRECTOR STOCK OPTION AGREEMENT dex1047.txt EX-10.47 19334
6 CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS dex231.txt EX-23.1 1025
7 INDEPENDENT AUDITOR'S CONSENT dex232.txt EX-23.2 1607
  Complete submission text file 0001021408-03-006292.txt   329048
Mailing Address 110 LITTLE FALLS RD FAIRFIELD NJ 07004-2193
Business Address 110 LITTLE FALLS RD FAIRFIELD NJ 07004-2193 9738820860
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16005 | Film No.: 03655149
SIC: 2833 Medicinal Chemicals & Botanical Products